Skip to main content
PLOS One logoLink to PLOS One
. 2021 Feb 11;16(2):e0246782. doi: 10.1371/journal.pone.0246782

Barriers and facilitators to prudent antibiotic prescribing for acute respiratory tract infections: A qualitative study with general practitioners in Malta

Erika A Saliba-Gustafsson 1,2,*, Anna Nyberg 3, Michael A Borg 4,5, Senia Rosales-Klintz 1,6, Cecilia Stålsby Lundborg 1
Editor: Wolfgang Himmel7
PMCID: PMC7877739  PMID: 33571265

Abstract

Background

Antibiotic resistance is a leading global public health concern and antibiotic use is a key driver. Effective interventions are needed to target key stakeholders, including general practitioners (GPs). In Malta, little is known about factors that influence GPs’ antibiotic prescribing, making it challenging to implement targeted interventions. We therefore aimed to explore GPs’ understanding of antibiotic use and resistance, and describe their perceived barriers and facilitators to prudent antibiotic prescribing for acute respiratory tract infections in Malta.

Methods

Face-to-face individual semi-structured interviews were held with a quota sample of 20 GPs in 2014. Interviews were audio recorded and transcribed verbatim, and later analysed iteratively using manifest and latent content analysis. Findings were collated in a socioecological model to depict how GPs as individuals are embedded within larger social systems and contexts, and how each component within this system impacts their prescribing behaviour.

Findings

We found that GPs’ antibiotic prescribing decisions are complex and impacted by numerous barriers and facilitators at the individual, interpersonal, organisational, community, and public policy level. Predominant factors found to impact GPs’ antibiotic prescribing included not only intrinsic GP factors such as knowledge, awareness, experience, and misconceptions, but also several external factors. At the interpersonal level, GPs’ perceived patient demand and behaviour to be a persistent issue that impacts their prescribing decisions. Similarly, some GPs found pressure from drug reps to be concerning despite being considered an important source of information. Organisational and public policy-level issues such as lack of access to relevant antibiotic prescribing guidelines and current antibiotic resistance data from the community, were also considered major barriers to appropriate antibiotic prescribing. Utilisation of diagnostic testing was found to be low and GPs’ perceptions on the introduction of rapid point-of-care tests to support antibiotic prescription decisions, were mixed.

Conclusion

This study revealed the complexity of the antibiotic prescribing decision and the numerous barriers and facilitators that impact it, visualised through a socioecological model. Addressing GPs’ antibiotic prescribing practices will require targeted and coordinated implementation activities at all levels to change behaviour and address misconceptions, whilst also improving the physical and social environment.

Trial registration number

NCT03218930; https://clinicaltrials.gov/ct2/show/NCT03218930.

Introduction

Antibiotic resistance (ABR) is a multi-sectoral challenge of leading global public health concern that threatens patient safety [1]. In Europe, an estimated 33,000 people die of antibiotic-resistant infections annually, with patients under 1 and over 64 years bearing the highest burden [2]. Antibiotic consumption is one of the main drivers of ABR [35], and the correlation is even stronger in southern European countries where consumption rates are highest [3].

In Europe, most antibiotics prescribed for systemic use are provided to patients in the community setting [6]. Acute respiratory tract infections (ARTIs) remain the most common indication, despite their self-limiting nature [5]. Indeed, antibiotics confer little benefit for most ARTIs and the risk for complications when withholding antibiotic treatment is minimal [711]. Studies have revealed a plethora of factors that influence general practitioners’ (GPs’) antibiotic prescribing, including clinical, patient, environmental and cultural factors, patient demand and expectations, and provider attitudes and characteristics [1215]. Despite the complexity, GPs often diagnose infections based on clinical features, prescribing antibiotics empirically without using rapid point-of-care tests (POCTs) [16]. This places uncertainty in GPs’ decision-making, who may prescribe antibiotics to be on the safe side.

Several antibiotic stewardship programmes and public campaigns have been implemented in the community to improve antibiotic prescribing for ARTIs, with varying results [1722]. However, behavioural interventions in high-consuming southern European countries remain scarce. Since 2013, Malta, a southern European country, has reported among the highest antibiotic consumption rates in Europe [2325]. In 2018, 42% of Maltese respondents claimed to have consumed at least one antibiotic course during the past calendar year (EU-average: 32%); almost all (96%) were prescribed by a medical doctor [23]. The top two reasons were sore throat (22%) and flu (14%) [23]. Similarly, we showed that 45.7% of patients with respiratory tract complaints were prescribed antibiotics by a GP between 2015 and 2016 [26]. Since the majority of antibiotic consumption in Malta occurs in the community [27], and most antibiotics are obtained through a medical prescription [23], identifying barriers and facilitators to GPs’ antibiotic prescribing is crucial to implement effective and targeted interventions. We therefore aimed to explore GPs’ understanding of antibiotic use and resistance, and describe their perceived barriers and facilitators to prudent antibiotic prescribing for ARTIs in Malta.

Methods

This study was part of the Maltese Antibiotic Stewardship Programme in the Community (MASPIC). The project aimed to improve GPs’ antibiotic prescribing behaviour for acute respiratory tract complaints in Malta through a tailored, multifaceted social marketing intervention [28].

Setting

In Malta, patients are not registered to a particular GP and are free to choose their own doctor. About two-thirds of primary care is provided by private sector GPs, primarily solo practitioners, and home visits are still in demand [29,30]. Many private GPs practice within consultation rooms situated in retail pharmacies, and patients pay out-of-pocket; no subsidy or reimbursement applies. In the public sector, GP clinics are walk-in clinics and services are free at point-of-delivery to all citizens. Antibiotics are prescription-only medicines by law, purchased out-of-pocket from private community pharmacies [31].

Study design and participants

A qualitative methodology was deemed appropriate to address our research question. Following a literature search, a semi-structured interview guide (S1 File) was developed and adapted to the local context. It was pilot tested with 6 GPs in March 2014 and revised accordingly. Registered GPs were eligible to participate if they worked part-time or full-time, and in the public and/or private sectors. Using quota sampling [32], all eligible GPs with an available phone number were listed and divided into strata based on: (i) years of experience, (ii) sex, and (iii) locality of residence. Thirty GPs were contacted, however 4 were ineligible and 6 declined participation. Ultimately 20 GPs participated (Table 1). Age ranged from 32–70 years (mean = 52 years). GP experience ranged from 7–45 years (mean = 26 years).

Table 1. General practitioners’ demographic characteristics (n = 20).

Frequency, n
Sex Male 14
Female 6
Age (years) 30–39 2
40–49 4
50–59 11
60–69 2
70–79 1
Experience in general practice (years) 0–9 2
10–19 3
20–29 10
30–39 3
40–49 2
Health sector of practice Public 4
Private 14
both 2

Data collection

Individual semi-structured interviews were held by the first author (EASG), a trained qualitative researcher, between August and September 2014. GPs were interviewed at locations convenient to them, often their own clinic outside patient hours. Interviews lasted 25 to 67 minutes (median = 40 minutes) and data were collected until saturation was reached. Interviews were audio recorded and transcribed verbatim.

Data analysis

EASG and AN (an experienced qualitative researcher) analysed interview transcripts iteratively using manifest and latent content analysis with an inductive approach [33,34]. Briefly, transcripts were read independently numerous times to get a sense of the whole. Meaning units were identified and abridged into condensed meaning units, from which codes were derived. Similar codes were grouped into sub-categories and coalesced into categories, then grouped into sub-themes to extract an overarching theme. Analysis was discussed repeatedly between EASG and AN, and later with all co-authors, until consensus was reached. Finally, findings were visualised in a socioecological model as described by McLeroy et al. [35], to depict how GPs’ behaviour is influenced by various processes and interactions at 5 levels: individual, interpersonal, organisational, community, and public policy.

Ethical considerations

Ethical approval was sought from the University of Malta Research Ethics Committee but deemed exempt. Nonetheless, standard ethical considerations were adhered to. Participants were informed verbally and in writing about the study’s aim and their role, and signed informed consent was obtained. Interviewees participated voluntarily and were free to withdraw from the study without consequence.

Findings

Our findings revealed one overarching theme, GPs’ antibiotic prescribing decisions are complex and impacted by numerous barriers and facilitators at the individual, interpersonal, organisational, community, and public policy level, and are presented over four sub-themes, supported by illustrative quotes. We found that GPs’ antibiotic prescribing is impacted by both intrinsic and extrinsic factors, including patient demand and behaviour, information from drug reps, communication and collaboration with other healthcare professionals, availability of guidelines, access to diagnostic testing, and ease of referral. This reflects how GPs as individuals are embedded within larger social systems and contexts, and how each component within this system impacts their prescribing. We therefore collated our findings into a socioecological model to provide an illustrative overview of barriers and facilitators impacting GPs’ antibiotic prescribing at all levels of the system (Fig 1).

Fig 1. Overview of barriers and facilitators identified to have an impact on GPs’ antibiotic prescribing at all levels of the socioecological model.

Fig 1

Sub-theme I: GPs’ views on antibiotic use and resistance, and the management of ARTIs

Category I: GPs’ views on antibiotic use, ABR, and the pathogenesis of ARTIs

Antibiotics were viewed as precious tools that must be used judiciously. GPs acknowledged that antibiotics should not be overprescribed but feared that delaying necessary antibiotic treatment could result in more complicated infections. Nevertheless, a “wait-and-see approach”, i.e., requesting patients call back or return for follow-up should they deteriorate, and delayed antibiotic prescription, were often perceived as good strategies to minimise antibiotic use, although seldom with the intention of limiting ABR.

“Antibiotics are obviously very important, very special and very precious drugs. Why? Because we are running out of them. … They are wonder drugs, you cure people, you save lives. We underestimate what we do because we’re continuously saving lives with them…” (GP-J; male private GP; 41 years’ experience).

GPs were aware that antibiotic misuse accelerates ABR, restricting treatment options if left uncontrolled. Many believed that ABR is on the rise in Malta because of antibiotic overuse and misuse (particularly for viral infections) by prescribers, pharmacists, and the public alike. GPs remarked that broad-spectrum antibiotics are overused and that patients self-medicate, are non-compliant, retain leftover antibiotics, and acquire antibiotics over the counter, although this practice has allegedly almost ceased following revision in prescription policies. Marketing of specific antibiotic classes by drug reps was also considered a driver.

“…in the community you can basically touch resistance. Often you prescribe something that used to work, and patients return saying it hasn’t worked.” (GP-I; male private GP; 39 years’ experience).

Few GPs opined that ABR directly impacted their practice. Rather, several GPs reported achieving good results when prescribing antibiotics although they noted that ABR forced them to prescribe more broad-spectrum antibiotics. GPs disagreed about antibiotic doses; some believed high doses are unnecessary, others favoured more aggressive antibiotic therapy to avoid resistance development. Seldom, GPs reported prescribing combination antibiotic therapy to ensure infection resolution or limit ABR development, although many believed this unnecessary.

Although GPs considered the majority (70–90%) of upper ARTIs to be viral, GPs found it difficult to determine their aetiology based on clinical presentation, particularly lower ARTIs. Some determined aetiology over time, typically waiting 2–5 days for an infection to resolve. GPs also often believed viral infections commonly progress to secondary bacterial infections, particularly in the elderly.

“There is a tendency for old, frail patients with viral infections to get secondary bacterial infections… It would be indicated that it is a viral infection but being an old patient, prescribing an antibiotic won’t do any harm.” (GP-A; male private GP; 30 years’ experience).

Infections non-responsive to antibiotic therapy were often believed to be antibiotic-resistant or progression from a viral infection to a secondary bacterial infection; few noted non-response could be due to antibiotics prescribed unnecessarily for a viral infection. Determining the cause of a non-responsive infection was perceived as challenging, particularly without local data, and sometimes resulted in the prescription of multiple antibiotic courses.

“It’s very difficult to know whether an infection is resistant or whether they are non-responsive to treatment because they never needed antibiotics in the first place.” (GP-B; female public GP; 25 years’ experience).

Category II: GPs’ self-reported antibiotic prescribing practices

Antibiotic prescribing was viewed by several GPs as their sole responsibility, however self-reported practices varied widely. GPs not in favour of prescribing antibiotics immediately often chose to delay antibiotic prescription, particularly in mild or suspected viral cases. They typically prescribed symptomatic relief and requested patients follow-up should they develop worsening or changing symptoms (typically within 5 days). If follow-up was not possible, GPs were more likely to prescribe antibiotics earlier.

“A viral illness will last five days. I prefer to wait, and if there is an increase in fever, a change in the symptoms, worsening cough, greenish phlegm, you’re going to start them on antibiotics at that stage.” (GP-G; female public GP; 19 years’ experience).

GPs acknowledged occasionally prescribing antibiotics without a focus of infection if in doubt or if they suspect the patient may deteriorate, safeguarding the patient and themselves. Some GPs described instances where patients deteriorated, were hospitalised, or died, and they themselves or their colleagues were accused of not prescribing antibiotics immediately. Consequently, fear of missing possible life-threatening illnesses led them to err on the side of caution, even if not always in line with the evidence base.

“I had an adult … I prescribed antibiotics and it turned out to be a virus … I still gave antibiotics … if I missed the boat this person would end up with either a rupture or hearing loss so you can’t afford not to give and then be blamed for not recognizing her condition. It is better to be on the safe side, both for myself and the patient.” (GP-M; male public/private GP; 23 years’ experience).

GPs considered several factors before prescribing antibiotics, including the patient’s smoking status, age, occupation, and co-morbidities. Several believed smokers more often present with bacterial infections and children often acquire viral infections. Elderly patients and patients with multiple co-morbidities, were more likely to require antibiotics early according to GPs, to avoid complications and hospitalisation.

“…often … I end up giving prophylactic antibiotics to 80-year-old patients because if you don’t you end up with a chest infection which is harder to treat. These are people who easily end up hospitalised…” (GP-K; male public/private GP; 19 years’ experience).

GPs often adjusted prescriptions to suit patients’ needs and preferences, to improve compliance. Antibiotic allergies or discomforting side effects (e.g., thrush, nausea/vomiting, diarrhoea) typically led GPs to tailor therapy, changing antibiotic class if necessary. Some GPs also considered flavour (particularly in children), dosage form and regimen, and preferred antibiotics with daily or bidaily regimens.

“Some patients have a real hard time swallowing large tablets and prefer smaller tablets. Compliance is really dependent on these small details.” (GP-F; female private GP; 25 years’ experience).

Category III: GPs’ views on diagnostic testing and its availability in Malta

Few GPs used diagnostic testing (e.g., X-rays, CRP tests, throat swabs, sputum cultures) unless they considered the patient’s condition complicated. Public GPs were more willing to utilise such services due to their availability through the national health service; private GPs often lacked access to diagnostic facilities. Very few GPs were familiar with rapid POCTs. In fact, rapid POCTs for ARTIs were largely unavailable and almost all GPs had never used them. Few private GPs had access to rapid strep tests and only one GP used them regularly. Nevertheless, several GPs expressed positive attitudes towards them and were willing to test them if reliable and time efficient. They believed rapid POCTs could decrease antibiotic overuse and help patients understand their condition and treatment plan. Others insisted they would unlikely rely on rapid POCTs; they would rather rely on their experience and clinical assessment. They perceived rapid POCTs as tools used when unsure of oneself.

“They [rapid tests] would absolutely be very helpful. … You can explain to patients that the results are positive which means you have a bacterial infection… It can be used to persuade the patient rather than basing it just on my clinical impression.” (GP-M; male public/private GP; 23 years’ experience).

Time was considered a barrier to diagnostic testing, including delays caused by referrals and receipt of test results. For rapid POCTs, GPs’ felt they lacked the necessary human resources and infrastructure, which would cause time delays, negatively impacting their practice. Cost was another deterrent among many private GPs. Many believed patients would be unwilling to pay, and that they cannot increase consultation costs as a result. Some believed they may lose clients who will seek care elsewhere instead. This combination of barriers and limited access to testing, often led GPs to prescribe antibiotics empirically, occasionally prescribing a second antibiotic if the first fails to respond, before referring the patient for further investigation.

“We prescribe antibiotics without carrying out bacteriological tests, so we use our clinical judgement to try form an idea of what the underlying bacteriology is and treat it accordingly with the best antibiotic to match the infection.” (GP-J; male private GP; 41 years’ experience).

Sub-theme II: Addressing patient behaviour, knowledge, and awareness through education

Category IV: GPs’ views on patient behaviour, knowledge, and awareness

Patient expectations, pressure and demand for antibiotics, non-compliance, and self-medication, were dominant problems reported by GPs. According to GPs, patients seek medical care upon onset of symptoms, even for self-limiting infections, and expect immediate cure.

“…if a patient woke up with a bad sore throat he’ll be seen immediately, and because of this, patients expect an immediate cure. You cannot tell them to come back in three days’ time, they simply wouldn’t grasp that.” (GP-O; male private GP; 26 years’ experience).

Some GPs found demanding patients impossible to persuade and reported that some patients express dissatisfaction when they do not get their way, sometimes threatening to consult another GP. This was viewed as a problem as GPs could lose patients and income as a result. Most GPs, however, felt largely unaffected by this behaviour. Experience was regarded an asset, giving GPs confidence to address such behaviour. Few GPs admitted to buckling under pressure occasionally, even when antibiotics are unnecessary. Some believed this to be harmless; others prescribed short courses, narrow-spectrum antibiotics, or delayed antibiotic prescriptions to reduce harm.

“…when I fail to convince patients, because they literally do not understand, after a lot of thought I figure… one out of ten won’t make … a difference.” (GP-G; female public GP; 19 years’ experience).

Some GPs felt that through increased awareness, antibiotic demand is decreasing, particularly among parents. Nonetheless, several GPs believed patients still harbour misconceptions including that fever requires antibiotics and antibiotics are anti-inflammatory drugs. According to GPs, many do not understand how to use antibiotics appropriately, cannot differentiate between viral and bacterial infections, and believe they cannot recover without antibiotics. Another reported misconception was that the body develops resistance to antibiotics.

Category V: GPs’ experiences with patient education

GPs reported dedicating lots of time towards patient education, viewing it as their responsibility. GPs typically informed patients about their diagnosis, disease progression, and symptom management. GPs also explained the importance of not overusing antibiotics, storing leftovers, self-medicating, or stopping treatment prematurely. Some tried to clarify how resistance develops and its repercussions, but considered it challenging. Although many successfully rationalised with persistent patients why antibiotics are unnecessary, some felt it was pointless when patients insist on getting antibiotics against their advice.

Sub-theme III: The role of other professionals

Category VI: Interpersonal dynamics between GPs and other healthcare professionals

GPs mentioned the importance of seeking advice from other physicians (GPs and other specialists) when necessary. Whilst GPs in health centres could rely on colleagues for guidance, some solo private GPs felt isolated. For many solo private GPs who rented clinics within pharmacies, working closely with pharmacists was considered advantageous. They appreciated having access to another healthcare professional to discuss treatment plans and request advice. Conversely, few GPs mentioned that pharmacists sometimes made GPs feel obliged to prescribe medicines.

“Some pharmacists give you horrible looks if the patient doesn’t leave the clinic with a prescription.” (GP-I; male private GP; 39 years’ experience).

Category VII: GPs’ interaction with drug reps

GPs frequently interacted with drug reps but had opposing views towards them and their influence on antibiotic prescription. Drug reps were viewed by many as important contact points, particularly in private practice. To these GPs, the educational and informative aspect of drug-repping was imperative, keeping them abreast with recent medical advancements. They were the GP’s few sources of information on ABR patterns, new drugs, and technologies.

Whilst many GPs appreciated drug reps as credible sources of information, others were sceptical. They believed that information is not always scientifically sound, biased, and sometimes fabricated, since drug reps are under pressure to boost sales. They mentioned that recommendations are based on foreign evidence, and that over the years, drug reps have recommended specific broad-spectrum antibiotics and larger doses as a strategy to prevent ABR. GPs were also wary of certain marketing strategies, e.g., lectures organised and/or sponsored by pharmaceutical companies, incentives, and promoting antibiotics for their anti-inflammatory effect. Several GPs reported pressure from drug reps to prescribe although most insisted it did not influence them.

“I do not think medical reps affect me much. I … take in all the information … but the final decision must be my own…” (GP-F; female private GP; 25 years’ experience).

Sub-theme IV: Primary care organisation, and the impact of public policy and guidelines on GPs’ antibiotic prescribing

Category VIII: Primary care organisation

GPs encountered challenges with the healthcare organisation, particularly communication among the primary, secondary, and tertiary sectors. Lack of IT infrastructure resulted in no electronic link with other healthcare providers, often delaying feedback from specialists and hospitals regarding referrals. These delays impacted continuity-of-care and frustrated GPs, deterring them from referring patients. Ensuring continuity-of-care was considered a very important aspect of patient care to many private GPs. Episodic care was believed to lead to a more defensive approach and possibly antibiotic over-prescription.

Category IX: Public policy and guidelines

Few GPs believed that the introduction of professional indemnity insurance in 2014, may have rendered more defensive prescribing practices, i.e., prescribing antibiotics to safeguard oneself from legal implications. Regarding availability of community antibiotic prescribing guidelines and data on local ABR rates, reports were mixed. Whilst public GPs accessed information online, few private GPs seemed aware of this resource; many claimed to have no access to guidelines, despite their availability on the National Antibiotic Committee’s webpage. Several GPs believed in the importance of following guidelines to support diagnosis and treatment, particularly in complicated cases, yet only two GPs actively looked up guidelines; others used them as a last resort. Seldom, GPs felt overburdened and were cynical towards guidelines, placing more value in their experience.

“Often when you reach my age, guidelines just make you laugh. If you want a frank and honest answer, I do not abide by guidelines. Sometimes they are stupid.” (GP-I; male private GP; 39 years’ experience).

GPs noted that ABR data were outdated, and based on inpatient or foreign data, making them less relevant for community practitioners. Several expressed a desire for current, local community data to guide prescribing guidelines and improve GPs’ trust in them. The lack of current ABR data and local guidelines was considered a major pitfall, leading GPs to prescribe more cautiously or aggressively. One GP insisted however, that antibiotics are not abused, rather overprescribed unintentionally; the lack of current local data forces GPs to prescribe antibiotics blindly, without knowing what drug to prescribe or at what dose. Consequently, GPs avoid risks, opting for antibiotics they know are safe and effective.

Discussion

To our knowledge, this is the first qualitative study conducted in Malta that identifies key barriers and facilitators to GPs’ antibiotic prescribing to inform the implementation of a tailored social marketing intervention. We identified numerous barriers and facilitators to appropriate antibiotic prescription. These were visualised and summarised through a socioecological model to depict the complexity of antibiotic prescribing. Such models can help address barriers and guide public health practice [36]. A recent systematic review and meta-ethnography of antibiotic prescribing for ARTIs by primary care professionals, highlighted an array of individual, interpersonal, and contextual-level influences on antibiotic prescription [37]. It was concluded that interventions must be context-specific and consider prescribers’ perceived roles and priorities to be accepted and effective [37], further stressing the importance of this study. Below we discuss key findings and suggest possible factors that could be targeted to develop effective interventions to promote prudent antibiotic prescription in Malta and similar contexts.

Individual-level factors: GP awareness and misconceptions

Although many GPs were aware that antibiotics are important drugs that should be used appropriately as misuse promotes ABR, GPs’ reports revealed some misconceptions on the pathogenesis of ARTIs that must be addressed. GPs’ self-reported behaviour also indicated that antibiotics, particularly broad-spectrum, are being overprescribed, as previously suggested [2326]. Like other studies [38,39], ABR was considered an important and growing problem both locally and abroad, yet GPs believed it seldom impacted them. ABR was attributed to rampant and repeated antibiotic overuse and misuse, particularly broad-spectrum antibiotics. This heightened awareness on ABR may however negatively impact prescribing and lead GPs to prescribe more broad-spectrum antibiotics [39].

Of concern, GPs seldom believed that non-response to treatment could be due to unnecessary antibiotic prescription for a viral infection. This would be the more likely scenario, given that upper ARTIs are typically viral and self-limiting [40]. Instead, a predominant view was that non-response to treatment was a consequence of a secondary bacterial infection. Although this phenomenon is possible [41], it appears to be over-estimated by GPs. This is especially relevant in Malta, where patients tend to consult GPs early in the course of their illness [26]. GPs typically waited at most five days before considering an infection to have developed into a bacterial infection. However, most uncomplicated viral ARTIs last around five to seven days and peak in severity between days three and six [42]. For self-limiting ARTIs such as bronchitis and sinusitis, symptoms can last around three weeks (sometimes longer) without antibiotics [43], therefore prescribing antibiotics this early is likely premature.

Similar to previous findings [4449], GPs were more likely to prescribe antibiotics to the elderly and less likely to children. GPs believed that the elderly are more likely to deteriorate as a result of complications and secondary bacterial infections, whilst children are more likely to experience viral infections. GPs also believed smokers are more likely to deteriorate without antibiotics and were more inclined to prescribe antibiotics to them, corroborating our previous findings [44]. Although there is no evidence that antibiotics improve clinical outcomes in smokers [50], being a smoker has been found to be associated with antibiotic prescription in several studies [44,5052].

Interpersonal-level factors: Interaction with other key stakeholders

Patient demand and expectations

GPs experience and are influenced by patient pressure and demand to prescribe antibiotics, which could result in inappropriate antibiotic prescription [46,5357]. In our recent study, we found that GPs in Malta are more likely to prescribe antibiotics to patients who request them [44], as corroborated by some GPs in this study. GPs believed that patient demand is driven by their expectation for a “quick fix” and belief that antibiotics are the solution, as has been found elsewhere [53]. GPs also believed that some patients lack the necessary knowledge to understand why antibiotics are not always necessary, making them harder to persuade. Indeed, the public’s knowledge and awareness on appropriate antibiotic use remains low in Malta, lower than EU average [23].

Patient expectations and demands are often over-estimated by physicians however, and early expectation-setting is critical to meet patient needs and ensure satisfaction [58]. GPs often mentioned that dissatisfied patients sometimes threaten to consult elsewhere. Since many patients pay out-of-pocket, GPs may feel obliged to prescribe antibiotics to avoid losing clients, avoid reconsultation, and/or ensure patient satisfaction [59]. However, giving patients an antibiotic prescription does not necessarily guarantee satisfaction. Whilst some studies have shown that an antibiotic prescription improves patient satisfaction [54,60], others have indicated that proper examination and information (without antibiotics) leads to higher satisfaction [6164]. In fact, communication is sometimes valued more by patients than a prescription [65]. Given GPs’ interest in patient education in this setting, introducing educational tools, like images and charts, to support GPs, could be beneficial.

Influence of drug reps

Research shows that drug reps frequently visit GPs, providing one-on-one information during outreach visits [6668]. Despite most GPs claiming to be unaffected by drug reps, as corroborated by previous studies [69], exposure to information from pharmaceutical companies can negatively impact GPs’ quality of antibiotic prescribing. It could not only augment prescribing but also irrational prescription of the company’s drug [66,6871]. Such influences can potentially explain the predominance of broad-spectrum antibiotics in Malta in preference to narrower-spectrum alternatives, despite the former not being indicated epidemiologically [72]. It is relevant to highlight, that the proportion of drug reps to doctors in Malta is one of the highest in the EU. It is unlikely that local drug companies were willing to expend so many resources if they did not perceive a satisfactory return on investment. There is no evidence that exposure to promotional activities by pharmaceutical companies improves antibiotic prescribing, therefore continued exposure cannot be recommended [66].

Yet, although some GPs received drug reps with scepticism in our study, GPs often felt that drug reps’ educational and informative role was imperative, similar to other studies [69]. This was particularly prevalent in private solo practices where GPs experienced little interaction with other healthcare professionals. This demonstrates the need for alternate strategies, such as academic detailing, to disseminate scientifically-sound and evidence-informed guidelines. Similar to drug reps’ tactics, in academic detailing, physicians receive individual educational visits by trained healthcare professionals within their own professional setting [73]. It gives GPs the opportunity to reflect on their prescription behaviour and learn about guideline-concordant recommendations for appropriate pharmacotherapy [55]. This can successfully decrease antibiotic prescription rates whilst improving quality and guideline-concordance [74,75]. Since GPs lack time to attend formal lectures, we believe that with enough resources, this strategy can bring correct and timely information to GPs in this type of healthcare setting.

Organisational and public policy-level factors: Addressing diagnostic uncertainty

Lack of access to up-to-date national antibiotic guidelines and data on community ABR rates were considered major barriers to appropriate antibiotic prescription by GPs. Moreover, GPs lacked access to rapid POCTs and were often not familiar with them. GPs also acknowledged prescribing antibiotics without a definitive diagnosis out of fear of negative repercussions, and frequently expressed difficultly in differentiating between viral and bacterial infections. Diagnostic uncertainty is a major barrier to appropriate antibiotic prescription [53], that correlates with antibiotic misuse and overuse [14,15,76]. In cultures such as Malta, where uncertainty avoidance is a dominant cultural trait [77], we believe GPs could benefit from tools that help support decision-making, as discussed below.

Antibiotic prescribing guidelines

Few GPs believed in the importance of antibiotic prescribing guidelines in this study. Whilst older GPs believed that clinical experience is superior to guidelines, as shown elsewhere [78], GPs were also sceptical about the accuracy of community antibiotic prescribing guidelines which, according to them, were based on foreign guidelines and hospital ABR rates. Lack of trust in guidelines is a major barrier to uptake [78,79]. To build trust, establishment of local community surveillance systems for antibiotic prescribing and ABR, coupled with timely data dissemination to all GPs is critically needed. Surveillance is one of the pillars of ABR containment [1,80,81] and demands urgent attention in this setting. Additionally, guidelines should consider patient needs and preferences, including side effects to specific antibiotics, co-morbidities, and polypharmacy [78,79]. Such factors often affected GPs’ antibiotic prescribing decisions, therefore incorporating patient factors that influence GPs’ likelihood to deviate from recommendations, may further improve adherence.

Rapid POCTs

Rapid POCTs, such as point-of-care C-reactive protein testing, have been shown to reduce antibiotic prescribing rates cost-effectively [82]. When used appropriately, they can guide clinical management and mediate diagnostic certainty by providing GPs a better estimate of illness severity, particularly in settings where access to timely diagnostic services is limited. Rapid POCTs can also provide GPs with negotiating power and an educational opportunity with patients who insist on being prescribed antibiotics [83]. Consequently, GPs may succumb to patient demand less often [84,85], as shown in Spain, where POCTs decreased antibiotic prescription among patients who demanded antibiotics by 18.9% [84]. However, GPs in this study believed that introducing rapid POCTs may be impeded by time constraints, added costs, lack of resources, and patient hesitancy. Despite an overall positive outlook towards rapid POCTs, some GPs would still rather rely on clinical assessment, expecting rapid POCTs to have little impact on their prescribing decisions, as reported elsewhere [83]. Nonetheless, we firmly believe that introducing rapid POCTs in Malta should be considered, although their utility will need to be rigorously assessed to ensure successful scale-up on a national level.

Pharmacists, who already perform rapid POCTs like urinalyses and blood glucose testing in Malta, could possibly collaborate in this strategy. Evidence suggests that involving pharmacists to detect GAS pharyngitis using rapid POCTs and providing Penicillin V treatment when necessary, is more cost-effective than treatment provided by doctors [86]. This approach could alleviate the burden of introducing rapid POCTs into general practices. However, given that several pharmacists run their own private pharmacies in Malta, allowing pharmacists to dispense antibiotics could be impacted by financial gain and should not be overlooked.

Delayed antibiotic prescription

Finally, delayed antibiotic prescribing strategies can also reduce antibiotic use for ARTIs by 45–80%, without significant negative patient repercussions [8794]. GPs hold varying perceptions about delayed antibiotic prescription however, and there is variation in the way delayed antibiotic prescription strategies are used [9597]. Whilst this variation cannot be disregarded, appropriate and targeted delayed antibiotic prescription strategies have a role to play in reducing unnecessary antibiotic use, particularly in high uncertainty avoidance cultures, providing reassurance to both the patient and GP [95,98101]. Incorporating delayed antibiotic prescription into antibiotic prescribing guidelines is also recommended [95].

Strengths and limitations

The strength of our study lies in the richness of our data, which allowed us to present our findings in a socioecological model where antibiotic prescribing is shown to be impacted not only by intrinsic GP knowledge and awareness, but a myriad of factors at all levels of the model. Although context-specific, our findings are relevant not only to local GPs but could also be important in other contexts. It is important to note however, that our data only captures GPs’ views from 2014. Although still valuable and relevant given that little changes have occurred in this area in our context, further research should focus on better understanding and closely examining individual factors at all levels of the model, from various stakeholders’ perspectives. This would help better understand and address factors that influence antibiotic prescription in a more comprehensive manner.

Conclusion and recommendations

We identified key issues that must be addressed to successfully improve GPs’ antibiotic prescribing behaviour for ARTIs. Through a socioecological model, we visualised the problem’s complexity and the numerous influences on GPs’ antibiotic prescribing decisions and behaviour. Future local initiatives must combine efforts across all levels to change behaviour and address misconceptions, whilst also improving the physical and social environment. In particular, GPs need access to relevant antibiotic guidelines for the community and more training and education with a particular focus on guidelines and enhancing GP-patient communication. Finally, more research is needed to better understand the general public’s and pharmacists’ views and behaviour, to design appropriate intervention strategies across all key stakeholders.

Supporting information

S1 File

(DOCX)

Acknowledgments

We would like to express our immense gratitude to all GPs, for setting aside time from their hectic schedules to participate in this study.

Data Availability

All relevant data are presented in the paper. Since we present interview data, some information disclosed by general practitioners may make them identifiable, particularly since the study has been carried out in a small country. Providing full transcripts may compromise their identity and that of others, going against ethical considerations. All data are currently archived at the department for a minimum of 10 years as per the University's archiving policy. Our research group administrator, who is not a co-author on this paper, would be able to assist with any future data access requests. Her full name is: Vijaylakshmi Prabhu and her email address is: vijaylakshmi.prabhu@ki.se. Alternatively, one may directly contact the archivist using the following email address: registrator.gph@ki.se.

Funding Statement

This work was supported by Karolinska Institutet funding for doctoral education (KID-funding 3–1233/2013). It was also supported by funding available to CSL at Karolinska Institutet. This study received no other specific grant from any public, commercial or not-for-profit funding agencies. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.World Health Organization; Global action plan on antimicrobial resistance. Geneva, Switzerland: WHO; 2015. [DOI] [PubMed] [Google Scholar]
  • 2.Cassini A, Diaz Högberg L, Plachouras D, Quattrocchi A, Hoxha A, Skov Simonsen G, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66. 10.1016/S1473-3099(18)30605-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14:13 10.1186/1471-2334-14-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010;340:c2096 10.1136/bmj.c2096 [DOI] [PubMed] [Google Scholar]
  • 5.Goossens H, Ferech M, Vander Stichele R, Elseviers M, ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365(9459):579–587. 10.1016/S0140-6736(05)17907-0 [DOI] [PubMed] [Google Scholar]
  • 6.European Centre for Disease Prevention and Control. Surveillance of antimicrobial consumption in Europe, 2013–2014. Stockholm, Sweden: ECDC; 2018. [Google Scholar]
  • 7.Gulliford MC, Prevost AT, Charlton J, Juszczyk D, Soames J, McDermott L, et al. Effectiveness and safety of electronically delivered prescribing feedback and decision support on antibiotic use for respiratory illness in primary care: REDUCE cluster randomised trial. BMJ. 2019;364:1236 10.1136/bmj.l236 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Gulliford MC, Moore MV, Little P, Hay AD, Fox R, Prevost AT, et al. Safety of reduced antibiotic prescribing for self limiting respiratory tract infections in primary care: cohort study using electronic health records. BMJ. 2016;354:i3410 10.1136/bmj.i3410 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Meropol SB, Localio AR, Metlay JP. Risks and benefits associated with antibiotic use for acute respiratory infections: a cohort study. Ann Fam Med. 2013;11(2):165–172. 10.1370/afm.1449 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Butler CC, Hood K, Verheij T, Little P, Melbye H, Nuttall J, et al. Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ. 2009;338:b2242 10.1136/bmj.b2242 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Little P, Watson L, Morgan S, Williamson I. Antibiotic prescribing and admissions with major suppurative complications of respiratory tract infections: a data linkage study. Br J Gen Pract. 2002;52(476):187–193. [PMC free article] [PubMed] [Google Scholar]
  • 12.O’Connor R, O’Doherty J, O’Regan A, Dunne C. Antibiotic use for acute respiratory tract infections (ARTI) in primary care; what factors affect prescribing and why is it important? A narrative review. Ir J Med Sci. 2018;187(4):969–986. 10.1007/s11845-018-1774-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.McKay R, Mah A, Law MR, McGrail K, Patrick DM. Systematic review of factors associated with antibiotic prescribing for respiratory tract infections. Antimicrob Agents Chemother. 2016;60(7):4106–4118. 10.1128/AAC.00209-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Borg MA. National cultural dimensions as drivers of inappropriate ambulatory care consumption of antibiotics in Europe and their relevance to awareness campaigns. J Antimicrob Chemother, 2012;67(3):763–767. 10.1093/jac/dkr541 [DOI] [PubMed] [Google Scholar]
  • 15.Deschepper R, Grigoryan L, Stålsby Lundborg C, Hofstede G, Cohen J, Van Der Kelen G, et al. Are cultural dimensions relevant for explaining cross-national differences in antibiotic use in Europe? BMC Health Serv Res. 2008;8:123 10.1186/1472-6963-8-123 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Howick J, Cals JW, Jones C, Price CP, Plüddermann A, Heneghan C, et al. Current and future use of point-of-care tests in primary care: an international survey in Australia, Belgium, The Netherlands, the UK and the USA. BMJ Open 2014;4(8):e005611 10.1136/bmjopen-2014-005611 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.McDonagh MS, Peterson K, Winthrop K, Cantor A, Lazur BH, Buckley DI. Interventions to reduce inappropriate prescribing of antibiotics for acute respiratory tract infections: summary and update of a systematic review. J Int Med Res, 2018;46(8):3337–3357. 10.1177/0300060518782519 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Tonkin-Crine SK, Tan PS, van Hecke O, Wang K, Roberts NW, McCullough A, et al. Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews. Cochrane Database Syst Rev. 2017;9(9):CD012252 10.1002/14651858.CD012252.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Bernier A, Delarocque-Astagneau E, Ligier C, Vibet MA, Guillemot D, Watier L. Outpatient antibiotic use in France between 2000 and 2010: after the nationwide campaign, it is time to focus on the elderly. Antimicrob Agents Chemother. 2014;58(1):71–77. 10.1128/AAC.01813-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Formoso G, Paltrinieri B, Marata AM, Gagliotti C, Pan A, Moro ML, et al. Feasibility and effectiveness of a low cost campaign on antibiotic prescribing in Italy: community level, controlled, non-randomised trial. BMJ. 2013;347:f5391 10.1136/bmj.f5391 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Chahwakilian P, Huttner B, Schlemmer B, Harbarth S. Impact of the French campaign to reduce inappropriate ambulatory antibiotic use on the prescription and consultation rates for respiratory tract infections. J Antimicrob Chemother. 2011;66(12):2872–2879. 10.1093/jac/dkr387 [DOI] [PubMed] [Google Scholar]
  • 22.Huttner B, Goossens H, Verheij T, Harbarth S, CHAMP consortium. Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis. 2010;10(1):17–31. 10.1016/S1473-3099(09)70305-6 [DOI] [PubMed] [Google Scholar]
  • 23.TNS Opinion & Social. Special eurobarometer 478: antimicrobial resistance. Brussels, Belgium: European Commission; 2018. [Google Scholar]
  • 24.TNS Opinion & Social. Special eurobarometer 445: antimicrobial resistance. Brussels, Belgium: European Commission; 2016. [Google Scholar]
  • 25.TNS Opinion & Social. Special eurobarometer 407: antimicrobial resistance. Brussels, Belgium: European Commission; 2013. [Google Scholar]
  • 26.Saliba-Gustafsson EA, Dunberger Hampton A, Zarb P, Borg MA, Stålsby Lundborg C. Antibiotic prescribing for respiratory tract complaints in Malta: a 1 year repeated cross-sectional surveillance study. J Antimicrob Chemother. 2019;74(4):1116–1124. 10.1093/jac/dky544 [DOI] [PubMed] [Google Scholar]
  • 27.Zarb P, Borg MA. Consumption of antibiotics within ambulatory care in Malta. Malta Med J. 2011;23(2):13–18. [Google Scholar]
  • 28.Saliba-Gustafsson EA, Borg MA, Rosales-Klintz S, Nyberg A, Stålsby Lundborg C. Maltese Antibiotic Stewardship Programme in the Community (MASPIC): protocol of a prospective quasiexperimental social marketing intervention. BMJ Open. 2017;7(9):e017992 10.1136/bmjopen-2017-017992 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Azzopardi-Muscat N, Buttigieg S, Calleja N, Merkur S. Malta: health system review. Health Syst Transit. 2017;19(1):1–137. [PubMed] [Google Scholar]
  • 30.PricewaterhouseCoopers. Healthcare delivery in Malta. Malta: PricewaterhouseCoopers; 2012. [Google Scholar]
  • 31.Borg MA, Scicluna EA. Over-the-counter acquisition of antibiotics in the Maltese general population. Int J Antimicrob Agents. 2002;20(4):253–257. 10.1016/s0924-8579(02)00194-2 [DOI] [PubMed] [Google Scholar]
  • 32.Mack N, Woodsong C, MacQueen KM, Guest G, Namey E. Qualitative research methods: a data collector’s field guide. North Carolina, USA: FHI; 2005. [Google Scholar]
  • 33.Elo S, Kyngäs H. The qualitative content analysis process. J Adv Nurs. 2008;62(1):107–115. 10.1111/j.1365-2648.2007.04569.x [DOI] [PubMed] [Google Scholar]
  • 34.Graneheim UH, Lundman B. Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness. Nurse Educ Today. 2004;24(2):105–112. 10.1016/j.nedt.2003.10.001 [DOI] [PubMed] [Google Scholar]
  • 35.McLeroy KR, Bibeau D, Steckler A, Glanz K. An ecological perspective on health promotion programs. Health Educ Q. 1988;15(4):351–377. 10.1177/109019818801500401 [DOI] [PubMed] [Google Scholar]
  • 36.Golden SD, Earp JAL. Social ecological approaches to individuals and their contexts: twenty years of health education & behavior health promotion interventions. Health Educ Behav. 2012;39(3):364–372. 10.1177/1090198111418634 [DOI] [PubMed] [Google Scholar]
  • 37.Germeni E, Frost J, Garside R, Rogers M, Valderas JM, Britten N. Antibiotic prescribing for acute respiratory tract infections in primary care: an updated and expanded meta-ethnography. Br J Gen Pract. 2018;68(674):e633–645. 10.3399/bjgp18X697889 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Björkman I, Berg J, Viberg N, Stålsby Lundborg C. Awareness of antibiotic resistance and antibiotic prescribing in UTI treatment: a qualitative study among primary care physicians in Sweden. Scand J Prim Health Care. 2013;31(1):50–55. 10.3109/02813432.2012.751695 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Simpson SA, Wood F, Butler CC. General practitioners’ perceptions of antimicrobial resistance: a qualitative study. J Antimicrob Chemother. 2007;59(2):292–296. 10.1093/jac/dkl467 [DOI] [PubMed] [Google Scholar]
  • 40.Zoorob R, Sidani MA, Fremont RD, Kihlberg C. Antibiotic use in acute upper respiratory tract infections. Am Fam Physician. 2012;86(9):817–822. [PubMed] [Google Scholar]
  • 41.Hendaus MA, Jomha FA, Alhammadi AH. Virus-induced secondary bacterial infection: a concise review. Ther Clin Risk Manag. 2015;11:1265–1271. 10.2147/TCRM.S87789 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Wald ER, Applegate KE, Bordley C, Darrow DH, Glode MP, Marcy SM, et al. Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years. Pediatrics. 2013;132(1):e262–280. 10.1542/peds.2013-1071 [DOI] [PubMed] [Google Scholar]
  • 43.National Institute for Health and Care Excellence. Respiratory tract infections (self-limiting): prescribing antibiotics. London, UK: NICE; 2008. [PubMed] [Google Scholar]
  • 44.Saliba-Gustafsson EA, Dunberger Hampton A, Zarb P, Orsini N, Borg MA, Stålsby Lundborg C. Factors associated with antibiotic prescribing in patients with acute respiratory tract complaints in Malta: a 1-year repeated cross-sectional surveillance study. BMJ Open. 2019;9(12):e032704 10.1136/bmjopen-2019-032704 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Dallas A, Magin P, Morgan S, Tapley A, Henderson K, Ball J, et al. Antibiotic prescribing for respiratory infections: a cross-sectional analysis of the ReCEnT study exploring the habits of early-career doctors in primary care. Fam Pract. 2015;32(1):49–55. 10.1093/fampra/cmu069 [DOI] [PubMed] [Google Scholar]
  • 46.Dekker ARJ, Verheij TJM, van der Velden AW. Inappropriate antibiotic prescription for respiratory tract indications: most prominent in adult patients. Fam Pract. 2015;32(4):401–407. 10.1093/fampra/cmv019 [DOI] [PubMed] [Google Scholar]
  • 47.Haeseker MB, Dukers-Muijrers NHTM, Hoebe CJPA, Bruggeman CA, Cals JWL, Verbon A. Trends in antibiotic prescribing in adults in Dutch general practice. PLoS One. 2012;7(12):e51860 10.1371/journal.pone.0051860 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Rosman S, Le Vaillant M, Schellevis F, Clerc P, Verheij R, Pelletier-Fleury N. Prescribing patterns for upper respiratory tract infections in general practice in France and in the Netherlands. Eur J Public Health. 2008;18(3):312–316. 10.1093/eurpub/ckm118 [DOI] [PubMed] [Google Scholar]
  • 49.Akkerman AE, van der Wouden JC, Kuyvenhoven MM, Dieleman JP, Verheij TJM. Antibiotic prescribing for respiratory tract infections in Dutch primary care in relation to patient age and clinical entities. J Antimicrob Chemother. 2004;54(6):1116–1121. 10.1093/jac/dkh480 [DOI] [PubMed] [Google Scholar]
  • 50.Stanton N, Hood K, Kelly MJ, Huttall J, Gillespie D, Verheij T, et al. Are smokers with acute cough in primary care prescribed antibiotics more often, and to what benefit? An observational study in 13 European countries. Eur Respir J. 2010;35:761–767. 10.1183/09031936.00168409 [DOI] [PubMed] [Google Scholar]
  • 51.Manne M, Deshpande A, Hu B, Patel A, Taksler GB, Misra-Hebert AD, et al. Provider variation in antibiotic prescribing and outcomes of respiratory tract infections. South Med J. 2018;111(4):235–242. 10.14423/SMJ.0000000000000795 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Shallcross L, Beckley N, Rait G, Hayward A, Petersen I. Antibiotic prescribing frequency amongst patients in primary care: a cohort study using electronic health records. J Antimicrob Chemother. 2017;72(6):1818–1824. 10.1093/jac/dkx048 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Dempsey PP, Businger AC, Whaley LE, Gagne JJ, Linder JA. Primary care clinicians’ perceptions about antibiotic prescribing for acute bronchitis: a qualitative study. BMC Fam Pract. 2014;15:194 10.1186/s12875-014-0194-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Coenen S, Francis N, Kelly M, Hood K, Nuttall J, Little P, et al. Are patient views about antibiotics related to clinician perceptions, management and outcome? A multi-country study in outpatients with acute cough. PLoS One. 2013;8(10):e76691 10.1371/journal.pone.0076691 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Frich JC, Høye S, Lindbaek M, Straand J. General practitioners and tutors’ experiences with peer group academic detailing: a qualitative study. BMC Fam Pract. 2010;11(12). 10.1186/1471-2296-11-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Akkerman AE, Kuyvenhoven MM, van der Wouden JC, Verheij TJM. Determinants of antibiotic overprescribing in respiratory tract infections in general practice. J Antimicrob Chemother. 2005;56(5):930–966. 10.1093/jac/dki283 [DOI] [PubMed] [Google Scholar]
  • 57.Cockburn J, Pit S. Prescribing behaviour in clinical practice: patients’ expectations and doctors’ perceptions of patients’ expectations: a questionnaire study. BMJ. 1997;315(7107):520–523. 10.1136/bmj.315.7107.520 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Little P, Dorward M, Warner G, Stephens K, Senior J, Moore M. Importance of patient pressure and perceived pressure and perceived medical need for investigations, referral, and prescribing in primary care: nested observational study. BMJ. 2004;328(7437):444 10.1136/bmj.38013.644086.7C [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Murphy M, Byrne S, Bradley CP. Influence of patient payment on antibiotic prescribing in Irish general practice: a cohort study. Br J Gen Pract. 2011;61(590):e549–555. 10.3399/bjgp11X593820 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Ashworth M, White P, Jongsma H, Schofield P, Armstrong D. Antibiotic prescribing and patient satisfaction in primary care in England: cross-sectional analysis of national patient survey data and prescribing data. Br J Gen Pract. 2016;66(642):e40–46. 10.3399/bjgp15X688105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Thoolen B, de Ridder D, van Lensvelt-Mulders G. Patient-oriented interventions to improve antibiotic prescribing practices in respiratory tract infections: a meta-analysis. Health Psychol Rev. 2012;6(1):92–112. [Google Scholar]
  • 62.van Duijn HJ, Kuyvenhoven MM, Schellevis FG, Verheij TJM. Illness behaviour and antibiotic prescription in patients with respiratory tract symptoms. Br J Gen Pract. 2007;57(54):561–568. [PMC free article] [PubMed] [Google Scholar]
  • 63.Welschen I, Kuyvenhoven M, Hoes A, Verheij T. Antibiotics for acute respiratory tract symptoms: patients’ expectations, GPs’ management and patient satisfaction. Fam Pract. 2004;21(3):234–237. 10.1093/fampra/cmh303 [DOI] [PubMed] [Google Scholar]
  • 64.Butler CC, Rollnick S, Pill R, Maggs-Rapport F, Stott N. Understanding the culture of prescribing: qualitative study of general practitioners’ and patients’ perceptions of antibiotics for sore throats. BMJ. 1998;317(7159):637–642. 10.1136/bmj.317.7159.637 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Mangione-Smith R, McGlynn EA, Elliott MN, Krogstad P, Brook RH. The relationship between perceived parental expectations and pediatrician antimicrobial prescribing behavior. Pediatrics. 1999;103(4 Pt 1):711–718. 10.1542/peds.103.4.711 [DOI] [PubMed] [Google Scholar]
  • 66.Spurling GK, Mansfield PR, Montgomery BD, Lexchin J, Doust J, Othman N, et al. Information from pharmaceutical companies and the quality, quantity, and cost of physicians’ prescribing: a systematic review. PLoS Med. 2010;7(10):e1000352 10.1371/journal.pmed.1000352 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Prosser H, Almond S, Walley T. Influences on GPs’ decision to prescribe new drugs-the importance of who says what. Fam Pract. 2003;20(1):61–68. 10.1093/fampra/20.1.61 [DOI] [PubMed] [Google Scholar]
  • 68.Watkins C, Harvey I, Carthy P, Moore L, Robinson E, Brawn R. Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey. Qual Saf Health Care. 2003;12(1):29–34. 10.1136/qhc.12.1.29 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Fickweiler F, Fickweiler W, Urbach E. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians’ attitudes and prescribing habits: a systematic review. BMJ Open. 2017;7(9):e016408 10.1136/bmjopen-2017-016408 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Fernández-Álvarez I, Zapata-Cachafeiro M, Vázquez-Lago J, López-Vázquez P, Piñeiro-Lamas M, García Rodríguez R, et al. Pharmaceutical companies information and antibiotic prescription patterns: a follow-up study in Spanish primary care. PLoS One. 2019;14(8):e0221326 10.1371/journal.pone.0221326 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Muijrers PE, Grol RP, Sijbrandij J, Janknegt R, Knottnerus A. Differences in prescribing between GPs: impact of the cooperation with pharmacists and impact of visits from pharmaceutical industry representatives. Fam Pract. 2005;22(6):624–630. 10.1093/fampra/cmi074 [DOI] [PubMed] [Google Scholar]
  • 72.Borg MA, Camilleri L. Broad-spectrum antibiotic use in Europe: more evidence of cultural influences on prescribing behaviour. J Antimicrob Chemother. 2019;74(11):3379–3383. 10.1093/jac/dkz312 [DOI] [PubMed] [Google Scholar]
  • 73.O’Brien MA, Rogers S, Jamtvedt G, Oxman AD, Odgaard-Jensen J, Kristoffersen DT, et al. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2007;2007(4):CD000409 10.1002/14651858.CD000409.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Dyrkorn R, Gjelstad S, Espnes KA, Lindbæk M. Peer academic detailing on use of antibiotics in acute respiratory tract infections. A controlled study in an urban Norwegian out-of-hours service. Scand J Prim Health Care. 2016;34(2):180–185. 10.3109/02813432.2016.1163035 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Ilett KF, Johnson S, Greenhill G, Mullen L, Brockis J, Golledge CL, et al. Modification of general practitioner prescribing of antibiotics by use of a therapeutics adviser (academic detailer). Br J Clin Pharmacol. 2000;49(2):168–173. 10.1046/j.1365-2125.2000.00123.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Gaygısız Ü, Lajunen T, Gaygısız E. Socio-economic factors, cultural values, national personality and antibiotics use: a cross-cultural study among European countries. J Infect Public Health. 2017;10(6):755–760. 10.1016/j.jiph.2016.11.011 [DOI] [PubMed] [Google Scholar]
  • 77.Hofstede G, Hofstede G, Minkov M. Cultures and organisations: software of the mind (3rd ed). New York, USA: McGraw-Hill Education; 2010. [Google Scholar]
  • 78.Biezen R, Roberts C, Buising K, Thursky K, Boyle D, Lau P, et al. How do general practitioners access guidelines and utilise electronic medical records to make clinical decisions on antibiotic use? Results from an Australian qualitative study. BMJ Open. 2019;9(8):e028329 10.1136/bmjopen-2018-028329 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Carlsen B, Glenton C, Pope C. Thou shalt versus thou shalt not: a meta-synthesis of GPs’ attitudes to clinical practice guidelines. Br J Gen Pract. 2007;57(545):971–978. 10.3399/096016407782604820 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.O’Neill J. Tackling drug-resistant infections globally: final report and recommendations. London, UK: Review on Antimicrobial Resistance; 2016. [Google Scholar]
  • 81.World Health Organization. The evolving threat of antimicrobial resistance: options for action. Geneva, Switzerland: WHO; 2012. [Google Scholar]
  • 82.Oppong R, Jit M, Smith RD, Butler CC, Melbye H, Mölstad S, et al. Cost-effectiveness of point-of-care C-reactive protein testing to inform antibiotic prescribing decisions. Br J Gen Pract. 2013;63(612):e465–471. 10.3399/bjgp13X669185 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Butler CC, Simpson S, Wood F. General practitioners’ perceptions of introducing near-patient testing for common infections into routine primary care: a qualitative study. Scand J Prim Health Care. 2008;26(1):17–21. 10.1080/02813430701726285 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Llor C, Bjerrum L, Munck A, Cots JM, Hernández S, Moragas A, et al. Access to point-of-care tests reduces the prescription of antibiotics among antibiotic-requesting subjects with respiratory tract infections. Respir Care. 2014;59(12):1918–1923. 10.4187/respcare.03275 [DOI] [PubMed] [Google Scholar]
  • 85.Anthierens S, Tonkin-Crine S, Douglas E, Fernandez-Vandellos P, Krawcyzk J, Llor C, et al. General practitioners’ views on the acceptability and applicability of a web-based intervention to reduce antibiotic prescribing for acute cough in multiple European countries: a qualitative study prior to a randomised trial. BMC Fam Pract. 2012;13:101 10.1186/1471-2296-13-101 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Klepser DG, Bisanz SE, Klepser ME. Cost-effectiveness of pharmacist-provided treatment of adult pharyngitis. Am J Manag Care. 2012;18(4):e145–154. [PubMed] [Google Scholar]
  • 87.de la Poza Abad M, Mas Dalmau G, Moreno Bakedano M, González González AI, Canellas Criado Y, Hernández Anadón S, et al. Prescription strategies in acute uncomplicated respiratory infections: a randomized clinical trial. JAMA Intern Med. 2016;176(1):21–29. 10.1001/jamainternmed.2015.7088 [DOI] [PubMed] [Google Scholar]
  • 88.Little P, Moore M, Kelly J, Williamson I, Leydon G, McDermott L, et al. Delayed antibiotic prescribing strategies for respiratory tract infections in primary care: pragmatic, factorial, randomised controlled trial. BMJ. 2014;348:g1606 10.1136/bmj.g1606 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Høye S, Frich JC, Lindbæk M. Use and feasibility of delayed prescribing for respiratory tract infections: a questionnaire survey. BMC Fam Pract. 2011;12:34 10.1186/1471-2296-12-34 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Little P, Rumsby K, Kelly J, Watson L, Moore M, Warner G, et al. Information leaflet and antibiotic prescribing strategies for acute lower respiratory tract infection: a randomized controlled trial. JAMA. 2005;293(24):3029–3035. 10.1001/jama.293.24.3029 [DOI] [PubMed] [Google Scholar]
  • 91.Dowell J, Pitkethly M, Bain J, Martin S. A randomised controlled trial of delayed antibiotic prescribing as a strategy for managing uncomplicated respiratory tract infection in primary care. Br J Gen Pract. 2001;51(464):200–205. [PMC free article] [PubMed] [Google Scholar]
  • 92.Little P, Gould C, Williamson I, Moore M, Warner G, Dunleavey J. Pragmatic randomised controlled trial of two prescribing strategies for childhood acute otitis media. BMJ. 2001;322(7282):336–342. 10.1136/bmj.322.7282.336 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Cates C. An evidence based approach to reducing antibiotic use in children with acute otitis media: controlled before and after study. BMJ. 1999;318(7185):715–716. 10.1136/bmj.318.7185.715 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Little P, Williamson I, Warner G, Gould C, Gantley M, Kinmouth AL. Open randomised trial of prescribing strategies in managing sore throat. BMJ. 1997;314(7082):722–727. 10.1136/bmj.314.7082.722 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Saliba-Gustafsson EA, Röing M, Borg MA, Rosales-Klintz S, Stålsby Lundborg C. General practitioners’ perceptions of delayed antibiotic prescription for respiratory tract infections: a phenomenographic study. PLoS One. 2019;14(11):e0225506 10.1371/journal.pone.0225506 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.McDermott L, Leydon GM, Halls A, Kelly J, Nagle A, White J, et al. Qualitative interview study of antibiotics and self-management strategies for respiratory infections in primary care. BMJ Open. 2017;7(11):e016903 10.1136/bmjopen-2017-016903 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Francis NA, Gillespie D, Nuttall J, Hood K, Little P, Verheij T, et al. Delayed antibiotic prescribing and associated antibiotic consumption in adults with acute cough. Br J Gen Pract. 2012;62(602):e639–646. 10.3399/bjgp12X653561 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Raft CF, Bjerrum L, Arpi M, Jarløv JO, Nygaard Jensen J. Delayed antibiotic prescription for upper respiratory tract infections in children under primary care: physicians’ views. Eur J Gen Pract. 2017;23(1):190–195. 10.1080/13814788.2017.1347628 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Peters S, Rowbotham S, Chisholm A, Weardon A, Moschogianis S, Cordingley L, et al. Managing self-limiting respiratory tract infections: a qualitative study of the usefulness of the delayed prescribing strategy. Br J Gen Pract. 2011;61(590):e579–589. 10.3399/bjgp11X593866 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Kumar S, Little P, Britten N. Why do general practitioners prescribe antibiotics for sore throat? Grounded theory interview study. BMJ. 2003;326(7381):138 10.1136/bmj.326.7381.138 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Arroll B, Goodyear-Smith F, Thomas DR, Kerse N. Delayed antibiotic prescriptions: what are the experiences and attitudes of physicians and patients? J Fam Pract. 2002;51(11):954–959. [PubMed] [Google Scholar]

Decision Letter 0

Wolfgang Himmel

9 Sep 2020

PONE-D-20-11324

General practitioners’ understanding of antibiotic use and resistance, and perceived barriers and facilitators to prudent antibiotic prescribing: a qualitative study

PLOS ONE

Dear Dr. Saliba-Gustafsson,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

The two reviewers raised a couple of concerns that you should consider in a revised version (see end of mail). By the way, you will find most of the comments of Reviewer 2 in an additional file.

I also have some concerns and additional suggestions you which you will find also at the end of this mail.

Please submit your revised manuscript by Oct 24 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Wolfgang Himmel

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2.Thank you for stating the following in the Competing Interests section:

[I have read the journal's policy and the authors of this manuscript have the following competing interests: At the time of the study, SRK was employed at Karolinska Institutet, Sweden. She is currently employed by the European Centre for Disease Prevention and Control (ECDC). The views and opinions expressed herein are the authors’ own and do not necessarily state or reflect those of ECDC. ECDC is not responsible for the data and information collation and analysis and cannot be held liable for conclusions or opinions drawn. EASG, AN, MAB and CSL have no competing interests to declare.].

Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests).  If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

3.We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

4. Please include a caption for figure 1.

Additional Editor Comments:

A real strength of your paper is the ecological model, or say, the parallel consideration of the many influences on a personal, professional, organizational level and so on. And exactly this makes the paper attractive not only for GPs in Malta but also in other countries, even in those with a lower use of antibiotics. Therefore, I would recommend that you make clearer than to date that the method of the paper and its results could also be of interest for readers worldwide.

Similar to Reviewer 2, I would also recommend that you start with the ecological model directly at the beginning of the Results section so that readers get a good overview of what they can expect on the following pages and how you organized your analysis and presentation of results.

Like Reviewer 1, I recommend a significant shortening of the manuscript. Even if PlosOne is an online journal, we should consider the readers interest to read concise manuscripts (“to the point”). Medical journals, even those with a qualitative focus (such as Family Practice) have usually word limits around 3,000 to 4,000 words. As far as I see, your manuscript has more than 10,000 words (!) and I ask you to limit it by a maximum of 6,000 words (fewer words would be even better!). You will see some suggestions later in my comments that may help to reach this limit.

The title of the manuscript, although rather long, misses and important term: “respiratory tract infections”. A shorter version, including this term could be:

Barriers and facilitators to prudent antibiotic prescribing in respiratory tract infections – a qualitative interview study with general practitioners in Malta (or “acute resp. …,” as often used)

I’m sure you find alternatives if you don’t agree with my suggestion.

Although I like the ecological model that guided, or helped to organize, your analysis, I have some concerns with the definitions and contents of your sub-themes and categories. Of course, I don’t want to interfere in the analysis of your working group, but perhaps you may find some other definitions in one or another case or re-work some of the categories:

See, for example, the first sub-theme. This is more or less the title of the paper or what you want to study but not a precise sub-theme. Do you find a more appropriate one?

Another example is a strong overlapping of category 1 and category 3 of the first sub-theme. Especially here, you could cancel a lot of text and concentrate on those aspects that are really outstanding and significant.

Also, sub-theme 1 and parts of sub-theme 2 are overlapping, especially as far as patient behavior is the issue. Again, here is room for strengthening the manuscript.

For me, the title of sub-theme 3 is too ‘positive’, if we have in mind, for example, drug reps. A better alternative may simply be: “The role of other professionals”.

One last example is category 9 of sub-theme 4. I feel parts of this category have nothing to do with ‘organization’ and so on but more or less with ‘attitudes’ of GPs towards testing and would then go well with sub-theme 1 (and could, again, be shortened!).

The Discussion is much too long and addresses too many issues, many of them already extensively discussed in the relevant literature. Please concentrate on the most important results from your research and the consequences for GPs and the international state of the art. Perhaps you can/may structure the discussion under 2 main issues: “GPs’ conceptions and misconceptions” and “external factors”. Just an idea.

For the Conclusion, I would recommend to restrict yourselves to 2 paragraphs: one with a stronger focus on the Malta GPs, one on the international discussion and future research.

As Reviewer 1, I also recommend to be precise when talking about patients and their behavior. Mostly, it’s not ‘patients’ but ‘patients and their behavior as perceived by the interviewees’. That is especially important in the case of ‘patient demand’, most often a matter overestimated by doctors but then ‘real in their consequences’. I think you know the rather old, but still excellent work of Paul Little and colleagues (https://www.bmj.com/content/bmj/328/7437/444.full.pdf) where we learn: “… after controlling for patient preference, medical need, and clustering by doctor, doctors' perceptions of patient pressure were strongly associated with prescribing … In all cases, doctors' perception of patient pressure was a stronger predictor than patients' preferences.”

Two minor remarks:

At several places in your paper, you talk about a ‘wait and see’ approach in such a way that one may think this is in some contrast to a ‘delayed prescription’ approach. Reading this interview with Geoffrey Spurling (https://medicalxpress.com/news/2017-09-dose-wait-and-see-unnecessary-antibiotic.html, I see no difference, also when reading his original paper (https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004417.pub5/full?cookiesEnabled). By the way, you may cite the paper.

Maybe this paper, too, is worth to be referenced as an update of the Gulliford paper you cited:

https://pubmed.ncbi.nlm.nih.gov/30755451/

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The methods section could still use some additional information regarding sampling technique and also regarding the use of the socio ecological model.

Interview data is normally not made publically available as there is no consent for that given by the participants I assume

for further comments see attached document

Reviewer #2: The paper focuses on an important and timely health care issue. We read it with great interest. It is well structured and well written. Some aspects have already been described, but there are also new and interesting connections.

- line 118: „A target of 20 GPs was deemed necessary to ensure data saturation.“ – Is this a preliminary consideration? What does it result from? From my point of view, this is an unnecessary sentence, possibly delete it.

- line 160: EASG – that this is the author is not self-explanatory, I was thinking of a software. Please write e.g. „by autor EASG“ at the first time.

- It is written about RTI. This is very broad. Does it mean ARTI? Or can it be narrowed down if necessary?

- The results are very lengthy, maybe not everything has to be presented in every detail, please always concentrate on essentials. It is normal, that the categories can frequently not be separated accurately. Please avoid repeating yourself!

- The whole manuscript should be shortened, especially the results section. Here are some suggestions:

o Try to avoid overlapping passages: e.g. uncertainty of the GPs in line: 204 ff., 299-301 etc., 333-337) please in one section

o citation line 323-327 please delete (no new information)

o second citation line 403-406 please delete

o Category V, line 417-456: please cut, normal prescription behavior does not need to be described in every detail

o citation line 536-538 please delete

o citation line 566-570 please delete too

o line 583-589 please cut, e.g. „GPs often felt that they cannot afford to wait too long to treat patients as they can develop complications. Consequently they felt that they have no choice but to prescribe antibiotics without knowing whether they are truly warranted.“ could be deleted

o citation line 624-628 please delete, line 640-643, too

o line: 657 – 662 please cut (no new information)

o line 666-670: could be deleted

- The results regarding the GPs view on patients should be presented as such, that means: Please write about GPs perception of patients and not of patients as such. Your results are based on the way GPs experience and perceive their patients and are not based on patient views and reports themselves. This should be clear for the reader, e.g. “GPs perceive their patients to expect something…/ GPs have the feeling that their patients …. etc”.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Review PLOS one 2020.docx

PLoS One. 2021 Feb 11;16(2):e0246782. doi: 10.1371/journal.pone.0246782.r002

Author response to Decision Letter 0


23 Oct 2020

Editor Comments:

1. Please include a caption for figure 1.

RESPONSE: Caption for figure 1 now added to the manuscript (lines 143-144).

2. A real strength of your paper is the ecological model, or say, the parallel consideration of the many influences on a personal, professional, organizational level and so on. And exactly this makes the paper attractive not only for GPs in Malta but also in other countries, even in those with a lower use of antibiotics. Therefore, I would recommend that you make clearer than to date that the method of the paper and its results could also be of interest for readers worldwide.

RESPONSE: Thank you for your positive remark. We have added a sentence on this in the methodological considerations section and have moved our socioecological model to the beginning of our findings to show case our results better.

3. Similar to Reviewer 2, I would also recommend that you start with the ecological model directly at the beginning of the Results section so that readers get a good overview of what they can expect on the following pages and how you organized your analysis and presentation of results.

RESPONSE: We took your advice and that of the reviewer and moved the socioecological model to the beginning of the results section.

4. Like Reviewer 1, I recommend a significant shortening of the manuscript. Even if PlosOne is an online journal, we should consider the readers interest to read concise manuscripts (“to the point”). Medical journals, even those with a qualitative focus (such as Family Practice) have usually word limits around 3,000 to 4,000 words. As far as I see, your manuscript has more than 10,000 words (!) and I ask you to limit it by a maximum of 6,000 words (fewer words would be even better!). You will see some suggestions later in my comments that may help to reach this limit.

RESPONSE: Thank you and the reviewers for suggesting areas where the word count can be reduced. We condensed the manuscript significantly. The current word count is: 6079.

5. The title of the manuscript, although rather long, misses an important term: “respiratory tract infections”. A shorter version, including this term could be: ‘Barriers and facilitators to prudent antibiotic prescribing in respiratory tract infections – a qualitative interview study with general practitioners in Malta’ (or “acute resp. …,” as often used). I’m sure you find alternatives if you don’t agree with my suggestion.

RESPONSE: Thank you for this suggestion. We took it into consideration and re-worded the title similar to the one suggested.

6. Although I like the ecological model that guided, or helped to organize, your analysis, I have some concerns with the definitions and contents of your sub-themes and categories. Of course, I don’t want to interfere in the analysis of your working group, but perhaps you may find some other definitions in one or another case or re-work some of the categories:

• See, for example, the first sub-theme. This is more or less the title of the paper or what you want to study but not a precise sub-theme. Do you find a more appropriate one?

RESPONSE: Thank you for this comment. We changed the title as per your previous suggestion and have also rephrased the name of sub-theme 1. It now reads, “GPs’ views on antibiotic use and resistance, and their management of ARTIs”.

• Also, sub-theme 1 and parts of sub-theme 2 are overlapping, especially as far as patient behavior is the issue. Again, here is room for strengthening the manuscript.

• For me, the title of sub-theme 3 is too ‘positive’, if we have in mind, for example, drug reps. A better alternative may simply be: “The role of other professionals”.

RESPONSE: Thank you for pointing this out to us. We agree with you and have decided to rename the sub-theme to “The role of other professionals” as suggested.

• Another example is a strong overlapping of category 1 and category 3 of the first sub-theme. Especially here, you could cancel a lot of text and concentrate on those aspects that are really outstanding and significant.

One last example is category 9 of sub-theme 4. I feel parts of this category have nothing to do with ‘organization’ and so on but more or less with ‘attitudes’ of GPs towards testing and would then go well with sub-theme 1 (and could, again, be shortened!).

RESPONSE: After considering these very important points you raised, we decided to reorganize our findings, collapsing categories 1 and 3, and moving category 9 to sub-theme 1 instead of sub-theme 4. We also considered your earlier point on avoiding overlap between sub-themes 1 and 2, and editing/re-arranged our results accordingly.

7. The Discussion is much too long and addresses too many issues, many of them already extensively discussed in the relevant literature. Please concentrate on the most important results from your research and the consequences for GPs and the international state of the art. Perhaps you can/may structure the discussion under 2 main issues: “GPs’ conceptions and misconceptions” and “external factors”. Just an idea.

RESPONSE: Thank you for this comment and your suggestion. We condensed the discussion considerably and rearranged the flow, including less sub-headings (lines 380-521).

8. For the Conclusion, I would recommend to restrict yourselves to 2 paragraphs: one with a stronger focus on the Malta GPs, one on the international discussion and future research.

9. As Reviewer 1, I also recommend to be precise when talking about patients and their behavior. Mostly, it’s not ‘patients’ but ‘patients and their behavior as perceived by the interviewees’. That is especially important in the case of ‘patient demand’, most often a matter overestimated by doctors but then ‘real in their consequences’. I think you know the rather old, but still excellent work of Paul Little and colleagues (https://www.bmj.com/content/bmj/328/7437/444.full.pdf) where we learn: “… after controlling for patient preference, medical need, and clustering by doctor, doctors' perceptions of patient pressure were strongly associated with prescribing … In all cases, doctors' perception of patient pressure was a stronger predictor than patients' preferences.”

RESPONSE: Thank you for drawing our attention towards this again. We have made the necessary changes through the manuscript to ensure that patient behaviours and attitudes reported are based on GPs’ own reports and perceptions. Thank you also for raising the findings by Paul Little and colleagues. They are very relevant and so we have cited this study in our discussion under the patient demand and expectations sub-section.

Two minor remarks:

10. At several places in your paper, you talk about a ‘wait and see’ approach in such a way that one may think this is in some contrast to a ‘delayed prescription’ approach. Reading this interview with Geoffrey Spurling (https://medicalxpress.com/news/2017-09-dose-wait-and-see-unnecessary-antibiotic.html, I see no difference, also when reading his original paper (https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004417.pub5/full?cookiesEnabled). By the way, you may cite the paper.

RESPONSE: We have cut down significantly on discussion regarding delayed antibiotic prescription strategies since we have already published another paper on GPs specific views on delayed antibiotic prescription and their practices. We would however like to continue to differentiate between the two approaches in our findings, as this is how it was described by GPs.

There is variation in the literature in definitions around delayed antibiotic prescription strategies. We believed that the strategy is described quite eloquently by McDermott et al (2017) (PMID: 29180593). They categorise it into four strategies (all with the intention of delayed antibiotics): (i) providing an antibiotic prescription and instructing patients to use it after a given timeframe if symptoms persist or worsen (patient-led strategy), (ii) post-dating (or forward-dating) the prescription so that patients cannot purchase it before a specified date, (iii) instructing patients to return to collect the prescription at a later date if needed, or (iv) requesting that the patient call the clinic/practitioner to issue a prescription should certain criteria be met.

11. Maybe this paper, too, is worth to be referenced as an update of the Gulliford paper you cited: https://pubmed.ncbi.nlm.nih.gov/30755451/

RESPONSE: Thank you for drawing this article to our attention. It has now been cited.

Reviewers' comments to the author:

Reviewer #1:

1. The methods section could still use some additional information regarding sampling technique and the use of the socioecological model.

RESPONSE: Please see lines 118-121 where information was added about the inclusion of the socioecological model to illustrate our results.

2. Interview data is normally not made publicly available as there is no consent for that given by the participants I assume.

RESPONSE: That is correct. Requests to make interview data publicly available were never made (was never the intention to do so) and so participants did not consent to that which is why we will refrain from making data publicly available, particularly since the data were collected in a small setting which could possibly make participants identifiable.

Methods

3. Line 28: ‘quota sample’, what does this mean? How does this differ from purposeful sampling and how does this then link to concept of data saturation?

RESPONSE: Quota sampling is a form of purposive sampling but basically first splits the target group of interest into categories that are deemed important. For us for example, we wanted to ensure variation in, (i) years of experience, (ii) sex, and (iii) locality of residence based on the theory that antibiotic prescribing might differ among these three factors of interest. We could not break this down into other factors of interest, e.g. public versus private GPs because we did not have enough data to do so during data collection. By breaking down our sampling into these three categories, we ensured variation in our sample for those three factors of interest that was also proportional to the population we sampled from. Data saturation does not have anything to do with this sampling approach. We initially had a target of 20 GPs as often it has been shown in literature that 20 respondents are sufficient to ensure data saturation when using content analysis. In fact we did find that we had already reached saturation by GP 15 but continued to interview five more GPs because the interview had already been set up at that point.

4. Same comment to line 118, what kind of sampling was used? Do you mean with quota sampling some form of purposeful sampling?

RESPONSE: Please see comment above. Too make the article more concise, we removed the information on data saturation.

5. The interview data is already rather old as the interviews were done in 2014. It does not mean the data is not valuable anymore, but it would be good to put it in context of that time in qualitative research especially in the discussion section and limitation.

6. Line 149: had the interviewer some experience in qualitative research? Has she been trained in interviewing?

RESPONSE: Thank you for pointing this out. Yes, the first author has both training and experience in qualitative research. This has now been added to the methods (lines 106-107).

7. Line 164: what is the background of AN (as this might have an impact on the data analysis so it is good to know as a reader). Have both persons analysed all transcripts or only a few?

RESPONSE: AN has background in marketing and economy, and experience in qualitative research. Her insights brought an added dimension to the analysis which formed part of a larger project that utilised social marketing methods to identify key barriers and facilitators to antibiotic prescribing, to subsequently developed a targeted intervention, specifically addressing needs identified in this study. We added a short description on lines 112-114.

Results but linked with methods

There is an elaborate description of the many subthemes and then at the end there is a small description of the socioecological model, I think in my personal opinion, as I was reading through the results I was already thinking that applying that model would have been useful on the dataset. You do that at the end but maybe it would make the results section better if you organize it in that way from the beginning and explain this also in the method section, it will make the piece a lot stronger and easier to read.

RESPONSE: Thank you for sharing your views on this. As recommended, we shifted the results to start with the model. We also added a sentence in the data analysis section in the methods to describe how we used the model to illustrate our findings across all levels of the model (please see lines 119-122).

Discussion

In my view, the description of the results again could be shorted a bit or maybe interpreted a little bit more as it is now a bit repetitive of the results section. Maybe it could be useful to start from the socioecological model and link to the most important point that will need to be addressed in interventions. Also highlight what is new in your research compared to other research or what is more specific for Malta (as this is the reason why this research has been set up) than what you can find in the literature.

Methodological considerations

Starting from Line 908

“In qualitative research it is customary to use small, non-probability samples. We used quota sampling, a strategy that considers sizes and proportions of subsamples, in order to obtain subgroups that reflect corresponding proportions in the population and therefore attempt to gain a more representative picture”

I would not start with defending the ‘small sample’ in qualitative research this is normal and we shouldn’t defend it but it is important to be reflective about your sample, who have you sampled, who haven’t you got sampled, what might you have missed… to ensure quality of your data. Could you be a bit more reflective of your sample size, would there be potential participants that you might have missed? Data saturation is also linked to who you have selected for interviewing but also the interview questioning (the more structured the quicker you will get ‘saturation’ for example) but it is also linked to the experiences of the interviewer, how skilled are they? So it would be good to be a bit more reflective about that as well (and to mention also these skills in the method section) as these are (and some more) are essential criteria for saying we have data sufficiency.

I am not sure the aim in qualitative research is to get a representative picture for the whole population, but it is rather the aim is to find information rich cases to the phenomenon under investigation and personally I am more in favour of using the term ‘transferability’ to argue for the potential of wider relevance of the results which can be the result of the composition of the sample (i.e. diverse sample), rather than the sample size.

RESPONSE: Thank you for your comment. We have made edits to both the methods and methodological consideration sections based on your comments.

Reviewer #2:

8. Line 118: target of 20 GPs was deemed necessary to ensure data saturation. Is this a preliminary consideration? What does it result from? From my point of view, this is an unnecessary sentence, possibly delete it.

RESPONSE: This was a preliminary consideration as it is often shown that 20 informants are sufficient to ensure data saturation when using content analysis. During data collection we reach saturation by about the 15th interview but continued with already scheduled interviews to reach 20. However, as you rightly point out, this detailed information is unnecessary therefore for word count purposes this sentence has now been deleted.

9. Line 160: EASG – that this is the author is not self-explanatory, I was thinking of a software. Please write e.g. by author EASG at the first time.

RESPONSE: This was first described in the first line of the data collection section. We have retained it to avoid confusion. Please see line 106.

10. It is written about RTI. This is very broad. Does it mean ARTI? Or can it be narrowed down if necessary?

RESPONSE: Thank you for pointing this out. We have changed RTI to ARTI throughout since we interviewed GPs specifically about acute respiratory tract infections (both upper and lower).

11. The results are very lengthy, maybe not everything has to be presented in every detail, please always concentrate on essentials. It is normal, that the categories can frequently not be separated accurately. Please avoid repeating yourself!

RESPONSE: Thank you for your comment and advice. We reorganised the results and made a great effort to reduce the overall word count by condensing and text. The word count has now been reduced to 6079words.

12. The whole manuscript should be shortened, especially the results section. Here are some suggestions:

• Try avoiding overlapping passages: e.g. uncertainty of the GPs in line: 204 ff., 299-301 etc., 333-337) please in one section

• citation line 323-327 please delete (no new information)

• second citation line 403-406 please delete

• Category V, line 417-456: please cut, normal prescription behaviour does not need to be described in every detail

• citation line 536-538 please delete

• citation line 566-570 please delete too

• line 583-589 please cut, e.g. “GPs often felt that they cannot afford to wait too long to treat patients as they can develop complications. Consequently, they felt that they have no choice but to prescribe antibiotics without knowing whether they are truly warranted.” could be deleted

• citation line 624-628 please delete, line 640-643, too

• line: 657 – 662 please cut (no new information)

• line 666-670: could be deleted

RESPONSE: Thank you for these helpful suggestions. We took them all into consideration and efforts were made to reduce the overall word count by condensing and rearranging the text. The word count has been reduced to 6079 words.

13. The results regarding the GPs view on patients should be presented as such, that means: Please write about GPs perception of patients and not of patients as such. Your results are based on the way GPs experience and perceive their patients and are not based on patient views and reports themselves. This should be clear for the reader, e.g. “GPs perceive their patients to expect something… GPs have the feeling that their patients …. etc”.

RESPONSE: Thank you for drawing our attention towards this. We have made the necessary changes through the manuscript to ensure that patient behaviours and attitudes reported are based on GPs’ own reports and perceptions.

Attachment

Submitted filename: Rebuttal letter_2020.10.23.docx

Decision Letter 1

Wolfgang Himmel

10 Dec 2020

PONE-D-20-11324R1

Barriers and facilitators to prudent antibiotic prescribing for acute respiratory tract infections: a qualitative study with general practitioners in Malta

PLOS ONE

Dear Dr. Saliba-Gustafsson,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

While Reviewer 2 accepted the manuscript as it is, Reviewer 1 has still some minor concerns (see below) which I ask to consider for the final version. 

I have also some minor concerns and a major concern which you hopefully may address for the final version:

I would recommend to move the last sentence of the Findings section in the Abstract (“Findings were collated … prescribing.”) to the end of the Methods section. And you should present 2 or 3 more results in the Findings section of the Abstract. I think you have room enough there and it makes the Abstract more interesting and this may stimulate readers to read the whole paper.

You talk about a “formative” study at the beginning of the Methods. I’m afraid this is an unusual description of your study type and/or irritating for readers since they typically know this expression form educational research (summative – formative assessment). Is “qualitative” not sufficient – what do you think?

A better heading of Category III may be: “Why GPs use or do not use diagnostic tests”. I think it’s not so much “attitudes” that matter but structure (e. g., access to facilities, lack of resources and so on). Of course, your decision!

Perhaps “GPs’ experience in patient education” is a better heading for Category V (instead of “role”).

Following Reviewer 1, my major concern refers to the structure of your Discussion section. Your socioecological model is really interesting but I was disappointed that you did not use this innovative approach to structure your discussion. Instead, you discuss several of your results, sometimes with a subheading, sometimes without (e.g., when discussing the role of pharmacists). For the reader, this selection of issues and the structure of how you present them must appear arbitrary. I strongly recommend to try the following: Take the subheadings of your socioecological model as subheadings of your Discussion and discuss (as short as possible!) how the interviews with the GPs inform this model or to put it the other way how the barriers and facilitators to prudent prescribing cannot be understood if we only look at GPs and their education/knowledge. The model helps us to consider the many other factors that influence antibiotic prescribing. I know that the first three areas or levels of the model are far better represented in your interview material than “community” and “public policy”, but, for example, guidelines and insurance do play a role in “public policy” for GPs, as you found out.

So, please try to structure the discussion this way and get back to me if it is impossible. If it is possible (and I do hope so!) you should report one important “limitation” of your study or study design. Even if the model helps to better understand antibiotic prescribing, your study only captures the model as seen/perceived by the GPs. Further research should examine the 5 areas of the model not alone from the GP perspective but as ‘realities’ of their own. Questions, for example, could be: Did information campaigns take place and did they change antibiotic prescriptions ad so on. I think your paper could show how the future of research in drug prescribing could be and what elements are needed. Take the chance!

I’m sure this revision will not take so much time as the last revision and I look forward to your final version.

Please submit your revised manuscript by Jan 24 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Wolfgang Himmel

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: dear authors,

well done on addressing comments adequately apart from comment 5 about the data been collected in 2014, so still valuable but it might already be a bit dated, so you need to address this in the strenght and limitation section.

The discussion still needs a bit of work I think, as you have used the socio ecological model I would expect to find some findings and implications related to those different levels (intrapersonal, interpersonal, organisation and community and policy level)

word count is still a lot, I personally find an article of more then 5000 words too lenghty and people might not read it. It is worth trying to get the essence said in under 5000 words

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: prof dr Sibyl Anthierens

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Feb 11;16(2):e0246782. doi: 10.1371/journal.pone.0246782.r004

Author response to Decision Letter 1


17 Jan 2021

Dear Dr Himmel,

Thank you for giving us the opportunity to revise our manuscript and for considering it publication in PLOS ONE. Thank you also to the you and the reviewer for taking the time to thoroughly critique our manuscript. Enclosed kindly find our responses to all comments received together with an updated version of our manuscript (both marked and unmarked). We made several new revisions to the manuscript, including restructuring the discussion and reducing the word count further.

We look forward to hearing back from you at your earliest convenience.

Kind regards,

ERIKA A. SALIBA-GUSTAFSSON, PHD

Academic Editor Comments:

1. I would recommend moving the last sentence of the Findings section in the Abstract (“Findings were collated … prescribing.”) to the end of the Methods section. And you should present 2 or 3 more results in the Findings section of the Abstract. I think you have room enough there and it makes the Abstract more interesting and this may stimulate readers to read the whole paper.

RESPONSE: We agree that it would be better to move the last sentence of our findings to the methods and have now done so. Thank you for pointing that out to us! We also presented additional findings in the abstract as recommended.

2. You talk about a “formative” study at the beginning of the Methods. I’m afraid this is an unusual description of your study type and/or irritating for readers since they typically know this expression form educational research (summative – formative assessment). Is “qualitative” not sufficient – what do you think?

RESPONSE: Thank you for pointing this out to us. To avoid any misunderstanding (and to further reduce the word count) we have now removed “formative” from the beginning of the Methods sections.

3. A better heading of Category III may be: “Why GPs use or do not use diagnostic tests”. I think it’s not so much “attitudes” that matter but structure (e. g., access to facilities, lack of resources and so on). Of course, your decision!

RESPONSE: Thank you for your comment. We have considered your recommendation and chose to revise the category to, “GPs’ views on diagnostic testing and its availability in Malta” (lines 252-253). We changed attitudes to views since the findings reflect GPs’ views of the situation in Malta, which is of course very much impacted by their lack of access to diagnostic testing facilities in this setting.

4. Perhaps “GPs’ experience in patient education” is a better heading for Category V (instead of “role”).

RESPONSE: Category V has now been rephrased to read “GPs’ experiences with patient education” (line 316).

5. Following Reviewer 1, my major concern refers to the structure of your Discussion section. Your socioecological model is really interesting but I was disappointed that you did not use this innovative approach to structure your discussion. Instead, you discuss several of your results, sometimes with a subheading, sometimes without (e.g., when discussing the role of pharmacists). For the reader, this selection of issues and the structure of how you present them must appear arbitrary. I strongly recommend to try the following: Take the subheadings of your socioecological model as subheadings of your Discussion and discuss (as short as possible!) how the interviews with the GPs inform this model or to put it the other way how the barriers and facilitators to prudent prescribing cannot be understood if we only look at GPs and their education/knowledge. The model helps us to consider the many other factors that influence antibiotic prescribing. I know that the first three areas or levels of the model are far better represented in your interview material than “community” and “public policy”, but, for example, guidelines and insurance do play a role in “public policy” for GPs, as you found out. So, please try to structure the discussion this way and get back to me if it is impossible.

RESPONSE: Thank you for your comment. We have taken your advice into consideration and restructured the discussion to highlight key issues whilst better reflecting the socioecological model. Since organisational-level and public policy-level factors have a great impact on diagnostic uncertainty, which is discussed in the paper, we chose to combine the two, splitting that sub-section into various headings relevant to those levels of the socioecological model.

6. If it is possible (and I do hope so!) you should report one important “limitation” of your study or study design. Even if the model helps to better understand antibiotic prescribing, your study only captures the model as seen/perceived by the GPs. Further research should examine the 5 areas of the model not alone from the GP perspective but as ‘realities’ of their own. Questions, for example, could be: Did information campaigns take place and did they change antibiotic prescriptions and so on. I think your paper could show how the future of research in drug prescribing could be and what elements are needed. Take the chance!

RESPONSE: Thank you for pointing this out. We have changed our methodological considerations to focus on strengths and limitations of the study, to include both limitations related to only including one perspective (the GPs’) but also to address reviewer #1’s comment (that the data dates to 2014). It is worth noting however, that little has changed since 2014 in this context, so our findings are still relevant.

Reviewers' Comments:

Reviewer #1:

Dear authors, well done on addressing comments adequately apart from comment 5 about the data been collected in 2014, so still valuable but it might already be a bit dated, so you need to address this in the strength and limitation section.

The discussion still needs a bit of work I think, as you have used the socioecological model, I would expect to find some findings and implications related to those different levels (intrapersonal, interpersonal, organisation and community and policy level) word count is still a lot, I personally find an article of more than 5000 words too lengthy and people might not read it. It is worth trying to get the essence said in under 5000 words.

RESPONSE: Thank you for your comments. We have done our utmost to address these concerns. Please see our responses below.

• We have included a strengths and limitations section that raises the issue of our data being collected in 2014.

• Discussion has been re-structured to reflect the socioecological model better.

• We noted your concern regarding the word count and reduced it further.

Attachment

Submitted filename: Response to reviewers_2021.01.16.docx

Decision Letter 2

Wolfgang Himmel

27 Jan 2021

Barriers and facilitators to prudent antibiotic prescribing for acute respiratory tract infections: a qualitative study with general practitioners in Malta

PONE-D-20-11324R2

Dear Dr. Saliba-Gustafsson,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Wolfgang Himmel

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Dear authors,

I would like to add that it was a pleasure to read both revisions and to see how the paper improved during the revisions so that is now a clearly written paper and will add to our knowledge. I do hope that you share my view although it was a lot of work for you (I appreciate it!).

By the way, when you submit the final version, you may consider to change the heading of the subchapter 'Organisational and public policy-level factors: addressing diagnostic uncertainty' simply into 'Addressing organisational, community and public policy factors'. Thus, you could include the 'community' level so that all levels of the Figure are addressed in the Discussion. And perhaps you may add a sentence somewhere in this section, such as: "Educational activities and information campaigns in the community could help to support the adequate prescription and use of antibiotics" (sorry for my English). Indeed, I think this is one message of the Figure and it is important not only to call on doctors but to include the community when implementing a prudent drug strategy.

But, of course, it is your decision whether or not you follow my suggestion.

Thanks, Wolfgang Himmel

Reviewers' comments:

Acceptance letter

Wolfgang Himmel

1 Feb 2021

PONE-D-20-11324R2

Barriers and facilitators to prudent antibiotic prescribing for acute respiratory tract infections: a qualitative study with general practitioners in Malta

Dear Dr. Saliba-Gustafsson:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Wolfgang Himmel

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File

    (DOCX)

    Attachment

    Submitted filename: Review PLOS one 2020.docx

    Attachment

    Submitted filename: Rebuttal letter_2020.10.23.docx

    Attachment

    Submitted filename: Response to reviewers_2021.01.16.docx

    Data Availability Statement

    All relevant data are presented in the paper. Since we present interview data, some information disclosed by general practitioners may make them identifiable, particularly since the study has been carried out in a small country. Providing full transcripts may compromise their identity and that of others, going against ethical considerations. All data are currently archived at the department for a minimum of 10 years as per the University's archiving policy. Our research group administrator, who is not a co-author on this paper, would be able to assist with any future data access requests. Her full name is: Vijaylakshmi Prabhu and her email address is: vijaylakshmi.prabhu@ki.se. Alternatively, one may directly contact the archivist using the following email address: registrator.gph@ki.se.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES